2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC676
Submitter : Mrs. Adele Todd Date & Time: 10/12/2005 06:10:48
Organization : Mrs. Adele Todd
Category : Individual Consumer
Issue Areas/Comments
1
A. Should FDA initiate a rulemaking to codify its interpretation of section 503(b) of the action regarding when an active ingredient can be simultaneously marketed in both prescription drug product and an OTC drug product?
This drug kills babies.
GENERAL
GENERAL
PLEASE do not allow this abortion causing drug to be available OTC; a scientific link exists between abortion and breast cancer, and next they'll be suiing the FDA for cancer.